Glucagon-like peptide-1 7-36 amide

Drug Profile

Glucagon-like peptide-1 7-36 amide

Alternative Names: GLP-1 (7-36) amide

Latest Information Update: 29 Jun 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Novo Nordisk
  • Class Glucagon-like peptides
  • Mechanism of Action Gastric inhibitory polypeptide stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Obesity in Denmark (Infusion)
  • 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Obesity in Sweden (Infusion)
  • 29 Jun 2004 Discontinued - Clinical-Phase-Unknown for Obesity in USA (Infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top